stockrow
Friday 6 November 2026
Export IRTC’s income statement to Excel — free account
iRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
90.26
39.93
−30.67%
Follow IRTC
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 5 | 3 | 4 | 4 | 3 | 3 | 2 | 5 | 5 |
P/S ratio |
2.47 | 13.14 | 11.27 | 8.02 | 24.83 | 10.69 | 6.85 | 6.28 | 4.75 | 7.60 |
Altman Z-Score |
1.81 | 13.51 | 13.50 | 5.44 | 23.35 | 10.61 | 7.05 | 7.23 | 1.78 | 4.02 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 164.50 |
Altman Z″-Score (non-manufacturers) |
3.38 | 1.19 | (3.36) | (0.56) | 3.60 | 0.37 | (1.37) | (3.94) | 0.39 | 0.78 |
Beneish M-Score |
(1.58) | (2.97) | (3.16) | 1.20 | (2.59) | (2.67) | (3.54) | (2.99) | (3.41) | (3.04) |
P/Operating CF |
(169.01) | (349.95) | (379.51) | (353.98) | 842.10 | (264.62) | 223.80 | (193.70) | 146.26 | 216.65 |
P/B ratio |
1.71 | 16.38 | 31.83 | 12.70 | 19.27 | 12.35 | 11.74 | 14.73 | 30.94 | 37.18 |
Price to Tangible BV |
1.73 | 16.56 | 32.37 | 12.79 | 19.32 | 12.39 | 11.78 | 14.79 | 31.24 | 37.39 |
EV/Sales |
1.32 | 12.45 | 10.98 | 7.53 | 23.69 | 10.02 | 6.44 | 6.10 | 4.96 | 7.70 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(5.08) | (82.79) | (55.60) | (73.86) | (456.52) | (85.67) | (115.07) | (60.01) | 865.93 | 71.18 |
EV/FCF |
(4.36) | (66.83) | (47.20) | (38.16) | (230.00) | (49.14) | (50.11) | (33.21) | (96.08) | 166.74 |
Quick Ratio |
8.74 | 5.51 | 3.24 | 3.16 | 5.56 | 3.25 | 2.95 | 1.82 | 5.55 | 4.34 |
Current Ratio |
8.98 | 5.72 | 3.44 | 3.32 | 5.75 | 3.48 | 3.24 | 2.15 | 5.82 | 4.63 |
Net Debt/EBITDA |
5.01 | 2.66 | 1.01 | 2.06 | 8.32 | 2.46 | 1.88 | 0.91 | (1.26) | (2.12) |
Debt/Assets |
23.33% | 25.52% | 29.70% | 11.41% | 6.45% | 4.61% | 7.79% | 8.07% | 69.40% | 63.67% |
Debt/Equity |
0.35 | 0.43 | 0.67 | 0.26 | 0.10 | 0.08 | 0.15 | 0.17 | 7.11 | 4.25 |
Asset Turnover |
0.73 | 0.73 | 1.18 | 1.01 | 0.65 | 0.66 | 0.90 | 1.12 | 0.87 | 0.77 |
Operating CF/Net income |
0.80 | 0.50 | 0.58 | 0.40 | 0.31 | 0.37 | 0.20 | 0.41 | (0.03) | (1.82) |
Capex/Depreciation |
(3.37) | (1.92) | (2.09) | (5.88) | (1.85) | (2.44) | (1.56) | (2.36) | (1.80) | (1.75) |
Interest Coverage |
(4.80) | (8.15) | (14.67) | (33.33) | (28.75) | (85.49) | (27.50) | (34.29) | (9.01) | (4.36) |
| 461.33% | (34.56%) | (76.51%) | (58.19%) | (18.38%) | (32.64%) | (44.73%) | (54.86%) | (75.27%) | (36.57%) | |
| (23.75%) | (21.93%) | (40.20%) | (25.76%) | (10.72%) | (20.80%) | (25.50%) | (28.00%) | (16.60%) | (4.57%) | |
ROIC |
(52.22%) | (154.41%) | (328.50%) | (114.87%) | (69.28%) | (101.17%) | (115.44%) | (70.29%) | (35.77%) | (16.42%) |
Return on Tangible Assets |
(18.99%) | (28.36%) | (60.61%) | (37.07%) | (12.65%) | (37.05%) | (42.19%) | (54.23%) | (17.17%) | (6.34%) |
Average Days of Receivables |
53.58 | 47.69 | 49.05 | 40.60 | 41.20 | 52.50 | 44.34 | 45.55 | 49.30 | 36.98 |
Research and Development Expense of Revenue |
11.16% | 13.38% | 14.16% | 17.38% | 15.59% | 11.98% | 11.34% | 12.23% | 17.54% | 11.73% |
Selling, General and Administrative Expense of Revenue |
80.57% | 86.00% | 90.52% | 83.67% | 74.38% | 85.14% | 78.41% | 78.27% | 70.72% | 65.93% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
2.92% | 9.84% | 11.09% | 12.23% | 15.66% | 16.89% | 14.05% | 15.67% | 12.84% | 11.82% |
Graham Net Nets |
0.46 | 0.05 | 0.02 | 0.00 | 0.03 | 0.04 | 0.03 | 0.00 | (0.07) | (0.03) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(35.33%) | (2.26%) | (2.91%) | (3.20%) | (0.67%) | (2.93%) | (4.13%) | (4.00%) | (4.04%) | (0.79%) |
Free Cash Flow Yield |
(12.25%) | (1.42%) | (2.07%) | (2.46%) | (0.41%) | (1.91%) | (1.88%) | (2.93%) | (1.09%) | 0.61% |
Revenue per Share |
12.12 | 4.38 | 6.17 | 8.49 | 9.55 | 11.01 | 13.74 | 16.14 | 18.97 | 23.35 |
Operating CF per Share |
(3.15) | (0.66) | (1.22) | (0.87) | (0.50) | (1.29) | (0.77) | (1.64) | 0.11 | 2.53 |
Capex per Share |
(0.52) | (0.16) | (0.22) | (0.81) | (0.49) | (0.96) | (1.00) | (1.32) | (1.57) | (1.45) |
Free Cash Flow per Share |
(3.67) | (0.82) | (1.43) | (1.67) | (0.98) | (2.24) | (1.77) | (2.97) | (1.46) | 1.08 |
Cash per Share |
20.08 | 4.52 | 3.28 | 5.56 | 12.08 | 8.15 | 7.12 | 4.38 | 17.17 | 18.24 |
Shareholders Equity per Share |
17.51 | 3.52 | 2.18 | 5.36 | 12.31 | 9.53 | 8.02 | 6.88 | 2.91 | 4.77 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.51 | 3.52 | 2.18 | 5.36 | 12.31 | 9.53 | 8.02 | 6.88 | 2.91 | 4.77 |
Free Cash Flow |
(19.41) | (18.47) | (34.27) | (42.32) | (27.31) | (65.82) | (52.84) | (90.52) | (45.55) | 34.52 |
Working Capital |
105.39 | 98.66 | 73.96 | 120.73 | 312.16 | 217.67 | 199.68 | 123.44 | 534.90 | 550.88 |
Capital Expenditures |
(2.76) | (3.56) | (5.18) | (20.46) | (13.55) | (28.07) | (29.83) | (40.42) | (48.94) | (46.34) |
Net Current Asset Value |
73.01 | 66.01 | 38.91 | 1.99 | 207.70 | 122.07 | 80.36 | 7.77 | (194.72) | (164.53) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.10 | 0.05 | 0.09 | 0.07 | 0.08 | 0.08 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.18 | 0.30 | 0.27 | 0.13 | 0.21 | 0.21 | 0.25 | 0.16 | 0.22 | 0.17 |
Cash ROIC |
(8.41%) | (8.56%) | (20.72%) | (13.61%) | (3.85%) | (12.19%) | (10.83%) | (23.90%) | (3.58%) | 2.49% |
Accounts Receivable Turnover |
8.55 | 8.87 | 9.00 | 9.83 | 9.86 | 8.46 | 8.53 | 8.85 | 8.37 | 9.60 |
Accounts Payable Turnover |
11.73 | 12.54 | 16.58 | 9.97 | 11.15 | 14.69 | 14.34 | 24.64 | 28.88 | 46.40 |
Inventory Turnover |
16.48 | 18.36 | 20.72 | 17.21 | 15.03 | 14.02 | 10.17 | 11.05 | 13.16 | 12.33 |
Average Days of Payables |
36.76 | 31.00 | 21.49 | 57.32 | 22.67 | 35.11 | 21.22 | 12.58 | 14.30 | 3.74 |
Days of Inventory on Hand |
24.29 | 21.78 | 19.40 | 28.07 | 27.59 | 34.30 | 42.78 | 31.70 | 27.80 | 35.91 |
Average Receivables |
7.49 | 11.18 | 16.37 | 21.83 | 26.90 | 38.18 | 48.17 | 55.70 | 70.71 | 77.82 |
Average Payables |
1.78 | 2.25 | 2.34 | 5.26 | 6.30 | 7.44 | 9.01 | 6.53 | 6.38 | 4.74 |
Average Inventory |
1.27 | 1.54 | 1.87 | 3.05 | 4.68 | 7.79 | 12.71 | 14.56 | 14.01 | 17.84 |
Average Assets |
88.01 | 135.64 | 125.32 | 211.87 | 408.98 | 487.35 | 455.59 | 440.68 | 682.30 | 975.75 |
Average Common Equity |
(4.53) | 86.06 | 65.85 | 93.77 | 238.51 | 310.56 | 259.66 | 224.95 | 150.50 | 121.83 |
Columns are period end dates · fundamentals updated 5 Nov 2026